TY - JOUR
T1 - Suicide verdicts as opposed to accidental deaths in substance-related fatalities (UK, 2001–2007)
AU - Vento, A.E.
AU - Pompili, M.
AU - Schifano, Fabrizio
AU - Corkery, John
AU - Innamorati, M.
AU - Girardi, P.
AU - Ghodse, H.
N1 - Original article can be found at : http://www.sciencedirect.com/ Copyright Elsevier
PY - 2011
Y1 - 2011
N2 - Background : Substance-related deaths account for a great number of suicides. Aim : To investigate levels and characteristics of suicide verdicts, as opposed to accidental deaths, in substance misusers. Methods : Psychological autopsy study of cases from the UK National Programme on Substance Abuse Deaths (np-SAD) during the period 2001–2007. Results : Between January 2001 and December 2007, 2108 suicides were reported to the np-SAD. Typical suicide victims were White and older than 50 (respectively 95% and 41% of cases). Medications, especially antidepressants (44%), were prescribed to 87% of victims. Significantly fewer suicide victims than controls presented positive blood toxicological results for illicit drugs (namely: cocaine, heroin, amphetamines, ecstasy-type drugs, cannabis, and GHB/GBL) and alcohol. Conclusions : Suicide prevention programmes should devote specific attention to deaths among substance misusers who are at high risk of fatal intentional self-harm. Specific characteristics distinguish those at risk; caregivers should be better educated as to what these factors are. Limitations of the current study included lack of provision of comprehensive information relating to the victims' psychosocial variables. Furthermore, no differentiation between different classes of antidepressants in terms of involvement in suicide was here provided. Research highlights : Suicide among drug-related deaths can be characterised through a number of variables when compared with other causes of death. Suicide among drug-related deaths were more economically disadvantaged and had more medical problems. Suicides among these deaths were positive at blood toxicological tests for psychotropic drugs, and fewer suicide victims than controls had positive blood toxicological results for illicit drugs, alcohol, and methadone.
AB - Background : Substance-related deaths account for a great number of suicides. Aim : To investigate levels and characteristics of suicide verdicts, as opposed to accidental deaths, in substance misusers. Methods : Psychological autopsy study of cases from the UK National Programme on Substance Abuse Deaths (np-SAD) during the period 2001–2007. Results : Between January 2001 and December 2007, 2108 suicides were reported to the np-SAD. Typical suicide victims were White and older than 50 (respectively 95% and 41% of cases). Medications, especially antidepressants (44%), were prescribed to 87% of victims. Significantly fewer suicide victims than controls presented positive blood toxicological results for illicit drugs (namely: cocaine, heroin, amphetamines, ecstasy-type drugs, cannabis, and GHB/GBL) and alcohol. Conclusions : Suicide prevention programmes should devote specific attention to deaths among substance misusers who are at high risk of fatal intentional self-harm. Specific characteristics distinguish those at risk; caregivers should be better educated as to what these factors are. Limitations of the current study included lack of provision of comprehensive information relating to the victims' psychosocial variables. Furthermore, no differentiation between different classes of antidepressants in terms of involvement in suicide was here provided. Research highlights : Suicide among drug-related deaths can be characterised through a number of variables when compared with other causes of death. Suicide among drug-related deaths were more economically disadvantaged and had more medical problems. Suicides among these deaths were positive at blood toxicological tests for psychotropic drugs, and fewer suicide victims than controls had positive blood toxicological results for illicit drugs, alcohol, and methadone.
KW - substance abuse
KW - suicide
KW - accidental deaths
KW - United Kingdom
KW - antidepressants
U2 - 10.1016/j.pnpbp.2011.02.014
DO - 10.1016/j.pnpbp.2011.02.014
M3 - Article
SN - 0278-5846
VL - 35
SP - 1279
EP - 1283
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
IS - 5
ER -